# Changshu Guofa Venture

> Changshu Guofa Venture is a VC fund in Changshu backing Manufacturing and Medical. See 21 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Changshu, China
- Total investments: 21
- Last investment: May 2026
- Lead investor: 33%
- Last updated: Aug 2026
- Website: http://www.csgfct.com.cn

Changshu Guofa Venture is an investment firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Manufacturing | 7 | 33% |
| Medical | 4 | 19% |
| Biotechnology | 3 | 14% |
| Semiconductor | 3 | 14% |
| Industrial | 2 | 10% |

23 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 5 | 24% |
| Angel | 4 | 19% |
| Series B | 4 | 19% |
| Seed | 3 | 14% |
| Venture - Series Unknown | 3 | 14% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 20 | 95% |
| The Netherlands | 1 | 5% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Lyen Marine | LYEN is committed to designing and producing reliable, high-performance propeller systems, including FPP, CPP, and Azimuth thrusters. | $14.7M | Series B | May 22, 2026 |  |
| Furong Biotech | Furong Bio is a developer of innovative tumor immunology drugs. | $14.7M | Series B | May 20, 2026 |  |
| Xinmaide | Xinmaide focuses on the specialized fields of pulmonary drug delivery, nasal drug delivery, and brain drug delivery devices, dedicating its efforts to the research, design, and development of advanced medical technologies that improve how drugs are administered and absorbed in the body. | $43.7M | Series B | Apr 07, 2026 |  |
| Suihong Huachuang | Suihong Huachuang is a provider of comprehensive AI computing power solutions. It is a subsidiary of A-share listed company Hongxin Electronics Group. | $29M | Angel | Mar 22, 2026 |  |
| Zhengdao Optoelectronic Materials | Zhengdao Optoelectronic Materials is a high-tech enterprise specializing in the manufacturing of electronic materials. |  | Series A | Feb 04, 2026 |  |
| Lovis | Lovis focuses on high-precision five-axis CNC machining services, serving clients in multiple high-end manufacturing sectors by delivering complex, tight-tolerance components with exceptional accuracy, surface quality, and reliability for industries such as aerospace, medical devices, automotive, and advanced equipment manufacturing. |  | Series A | Jan 26, 2026 |  |
| Borui Fman | Borui Fman is a high-tech enterprise specializing in the research and development of metal forming machine tools, dedicated to delivering advanced manufacturing solutions through precision engineering, intelligent technology, and continuous innovation. |  | Series A | Jan 21, 2026 |  |
| Qingbo Exploration | Qingbo Exploration is a hydrogen boat power system technology provider, dedicated to applying clean energy—hydrogen energy—to the marine sector. |  | Series A | Jan 13, 2026 |  |
| Chuguang 3D | Chuguang 3D is a optical micro-nano 3D sensor technology platform that focuses on research and development, and manufacturing of micro-nano-level optical three-dimensional sensing and measurement and testing instruments. |  | Angel | Mar 21, 2025 |  |
| Aiyi animal medicine | Aiyi Animal Medicine develops and produces veterinary biological products and veterinary chemical medications. | $13.7M | Series C | Jan 06, 2025 |  |

10 of 21 investments shown.

## Co-investors
- [Jolmo Capital](https://shizune.co/investors/profile/jolmo-capital-management) — VC Fund, 3 deals together
- [Suzhou International Development Venture Capital](https://shizune.co/investors/profile/suzhou-international-development-venture-capital) — VC Fund, 3 deals together
- [Oriza Seed Capital (Oriza Yuandian)](https://shizune.co/investors/profile/oriza-seed-capital) — VC Fund, 2 deals together
- [Su Venture Capital](https://shizune.co/investors/profile/su-venture-capital) — VC Fund, 2 deals together
- [Addor Capital](https://shizune.co/investors/profile/addor-capital) — VC Fund, 1 deal together
- [Bank of China](https://shizune.co/investors/profile/bank-of-china) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Changshu Guofa Venture invest in?

Changshu Guofa Venture invests primarily in Manufacturing, Medical and Biotechnology startups, most often at Series A and Angel stage. Most of the 21 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Changshu Guofa Venture last invest?

The most recent investment recorded for Changshu Guofa Venture closed in May 2026. Shizune tracks 21 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co